Correlation Between Paratek Pharmaceuticals and Immutep
Can any of the company-specific risk be diversified away by investing in both Paratek Pharmaceuticals and Immutep at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Paratek Pharmaceuticals and Immutep into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Paratek Pharmaceuticals and Immutep Ltd ADR, you can compare the effects of market volatilities on Paratek Pharmaceuticals and Immutep and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Paratek Pharmaceuticals with a short position of Immutep. Check out your portfolio center. Please also check ongoing floating volatility patterns of Paratek Pharmaceuticals and Immutep.
Diversification Opportunities for Paratek Pharmaceuticals and Immutep
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Paratek and Immutep is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Paratek Pharmaceuticals and Immutep Ltd ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immutep Ltd ADR and Paratek Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Paratek Pharmaceuticals are associated (or correlated) with Immutep. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immutep Ltd ADR has no effect on the direction of Paratek Pharmaceuticals i.e., Paratek Pharmaceuticals and Immutep go up and down completely randomly.
Pair Corralation between Paratek Pharmaceuticals and Immutep
Given the investment horizon of 90 days Paratek Pharmaceuticals is expected to generate 1.33 times more return on investment than Immutep. However, Paratek Pharmaceuticals is 1.33 times more volatile than Immutep Ltd ADR. It trades about 0.04 of its potential returns per unit of risk. Immutep Ltd ADR is currently generating about 0.02 per unit of risk. If you would invest 196.00 in Paratek Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of 22.00 from holding Paratek Pharmaceuticals or generate 11.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 31.24% |
| Values | Daily Returns |
Paratek Pharmaceuticals vs. Immutep Ltd ADR
Performance |
| Timeline |
| Paratek Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Immutep Ltd ADR |
Paratek Pharmaceuticals and Immutep Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Paratek Pharmaceuticals and Immutep
The main advantage of trading using opposite Paratek Pharmaceuticals and Immutep positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Paratek Pharmaceuticals position performs unexpectedly, Immutep can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will offset losses from the drop in Immutep's long position.| Paratek Pharmaceuticals vs. Corvus Pharmaceuticals | Paratek Pharmaceuticals vs. Immutep Ltd ADR | Paratek Pharmaceuticals vs. Lyra Therapeutics | Paratek Pharmaceuticals vs. Equillium |
| Immutep vs. Ocean Biomedical | Immutep vs. Elevation Oncology | Immutep vs. Zura Bio Limited | Immutep vs. Cns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |